These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31477260)

  • 1. Hepcidin.
    Agarwal AK; Yee J
    Adv Chronic Kidney Dis; 2019 Jul; 26(4):298-305. PubMed ID: 31477260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease.
    Malyszko J; Malyszko JS; Matuszkiewicz-Rowinska J
    Expert Opin Ther Targets; 2019 May; 23(5):407-421. PubMed ID: 30907175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents.
    Weir MR
    Am J Nephrol; 2021; 52(6):450-466. PubMed ID: 34280923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology and pharmacology of hepcidin.
    Ruchala P; Nemeth E
    Trends Pharmacol Sci; 2014 Mar; 35(3):155-61. PubMed ID: 24552640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misdistribution of iron and oxidative stress in chronic kidney disease.
    Nakanishi T; Kuragano T; Nanami M; Nagasawa Y; Hasuike Y
    Free Radic Biol Med; 2019 Mar; 133():248-253. PubMed ID: 29958932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
    Nakanishi T; Kimura T; Kuragano T
    Contrib Nephrol; 2019; 198():124-134. PubMed ID: 30991414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
    Wang C; Fang Z; Zhu Z; Liu J; Chen H
    Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases.
    Poggiali E; Migone De Amicis M; Motta I
    Eur J Intern Med; 2014 Jan; 25(1):12-7. PubMed ID: 23988263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Metabolism in Chronic Kidney Disease Patients.
    Honda H; Hosaka N; Ganz T; Shibata T
    Contrib Nephrol; 2019; 198():103-111. PubMed ID: 30991401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
    Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
    Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
    Coyne DW
    Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron sequestration and anemia of inflammation.
    Ganz T; Nemeth E
    Semin Hematol; 2009 Oct; 46(4):387-93. PubMed ID: 19786207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia in chronic kidney disease.
    Atkinson MA; Warady BA
    Pediatr Nephrol; 2018 Feb; 33(2):227-238. PubMed ID: 28412770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD.
    Koury MJ; Haase VH
    Kidney Int; 2023 Jul; 104(1):25-28. PubMed ID: 37349056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.